Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Edmond Differding.
Letters in Peptide Science | 1995
Solo Goldstein; Michel Neuwels; Florence Moureau; Didier Berckmans; Marie-Agnes Lassoie; Edmond Differding; Raymond Houssin; Jean-Pierre Hénichart
Nine potent and selective substance P receptor antagonists (NK1 -) were analyzed with respect to their conformational space, with the aim to suggest probable conformations adopted at the receptor site and superposition rules for each structure (pharmacophore mapping). Key atoms within the ligands as well as receptor site points were considered in order to identify acceptable solutions (DISCO program). The results obtained allowed the suggestion or probable peptidic pharmacophores based on the structure of 1 (FK888). This knowledge was used to search commercial databases. The number and diversity of known retrieved NK1 antagonists allowed a general evaluation of the proposed pharmacophores. Moreover, a search in our proprietary database detected a short peptide with modest affinity but high selectivity for the NK1 receptor. The combination of molecular modeling with database searches is useful in a strategy aiming to develop new NK1 antagonists starting from existing knowledge.
Letters in Peptide Science | 1995
Solo Goldstein; Michel Neuwels; Patrick Culot; Edmond Differding; Charles Dogimont; Yvo van Assche; Marie-Hélène Brichard; Drina Jaspers; Georges Van Binst; A. Scarso; Jean-Pierre Hénichart
A comparative conformational analysis of two short pseudopeptides with ETB receptor affinity has been performed by molecular modelling and NMR techniques. This analysis aimed to get insight into probable biorelevant conformations and pharmacophoric patterns necessary for an efficient interaction with the receptor. Thus, it was shown that the two compounds can adopt γ-turn (or γ-turn-like) conformations, based on which the synthesis of particular, more rigid analogs might be proposed. The results obtained should prove valuable in a strategy aiming to design new endothelin antagonists following a peptide to non-peptide approach.
Journal of Medicinal Chemistry | 2004
Benoit Kenda; Alain Matagne; Patrice Talaga; Patrick Pasau; Edmond Differding; Bénédicte Lallemand; Anne Frycia; Florence Moureau; Henrik Klitgaard; Michel Gillard; Bruno Fuks; Philippe Michel
Archive | 2001
Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga
Archive | 1987
Jean-Pierre Geerts; Geneviève Motte; Edmond Differding; Jean-Pierre Henichart
Archive | 1995
Jean-Pierre Geerts; Geneviève Motte; Edmond Differding; Jean-Pierre Henichart
Archive | 2000
Ralph Scannell; Pierre Chatelain; Anna Toy-Palmer; Edmond Differding; James L. Ellis; Marie-Agnes Lassoie; Michelle Young; Xiong Cai; Sajjat Hussoin; Gurmit Grewal; Tim Lewis
Archive | 2005
Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga; ケンダ、ベノワ; タラガ、パトリス; ディファーディング、エドモンド; パソー、パトリック; マターニュ、アラン; ミシェル、フィリップ; ラルマン、ベネディクト
Archive | 2001
Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga
Archive | 2001
Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga